KPCB XIV Associates, LLC's Net Worth
$587 Million
Who is KPCB XIV Associates, LLC?
KPCB XIV Associates, LLC has an estimated net worth of $587 Million. This is based on reported shares across multiple companies, which include Foundation Medicine, Inc., BEYOND MEAT, INC., Oyster Point Pharma, Inc., ARMO BioSciences, Inc., and Thayer Ventures Acquisition Corp.
SEC CIK
KPCB XIV Associates, LLC's CIK is 0001546196
Past Insider Trading and Trends
2013 was KPCB XIV Associates, LLC's most active year for acquiring shares with 4 total transactions. KPCB XIV Associates, LLC's most active month to acquire stocks was the month of August. 2019 was KPCB XIV Associates, LLC's most active year for disposing of shares, totalling 8 transactions. KPCB XIV Associates, LLC's most active month to dispose stocks was the month of April. 2019 saw KPCB XIV Associates, LLC paying a total of $0.00 for 7,796,992 shares, this is the most they've acquired in one year. In 2018 KPCB XIV Associates, LLC cashed out on 8,533,366 shares for a total of $213,334,150.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Foundation Medicine, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -83.19% | -2.35M |
$50.00 | -$117,409,700.00 | 474.62K |
Apr 7
| |||
Form 4
| -80.70% | -2.28M |
$50.00 | -$113,900,600.00 | 544.8K |
Apr 7
| |||
Form 4
| -11.03% | -350.00K |
—
|
—
| 2.82M |
Jun 3
| |||
Form 4
| -9.94% | -350.00K |
—
|
—
| 3.17M |
May 27
| |||
Form 4
|
∞
| 3.52M |
—
|
—
| 3.52M |
Sep 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BEYOND MEAT, INC. (BYND) Snapshot price: $6.215
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -30.00% | -2.11M |
—
|
—
| 4.92M |
Oct 29
| |||
Form 4
| -9.34% | -723.86K |
$154.00 | -$111,474,748.00 | 7.03M |
Aug 5
| |||
Form 4
|
∞
| 7.75M |
—
|
—
| 7.75M |
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Oyster Point Pharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.12% | 45.53K |
—
|
—
| 367.99K |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARMO BioSciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.27M |
$50.00 | -$213,334,150.00 |
0
|
Jun 22
| |||
Form 4
|
∞
| 4.27M |
—
|
—
| 4.27M |
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Thayer Ventures Acquisition Corp (ISPO) Snapshot price: $3.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |